Could be down to metabolic differences or growth factor expression levels. As long as you have the appropriate controls you can use other strains but must be careful drawing conclusions when comparing to other studies that used a different train.
Because different strains of immunocompromised mice exhibit differing levels and types of residual immune effector cells, and this in turn may alter the efficiency of tumor cell engraftment.